Malaria Clinical Trial
Official title:
A Cost-effectiveness Analysis of Alternative Strategies for the Deployment of ACTs at the Community Level in Cameroon and Nigeria
The objective of the REACT project is to evaluate the effectiveness and cost-effectiveness implications of interventions designed to improve health worker practice in providing treatment for uncomplicated malaria to febrile patients attending health facilities in Cameroon and Nigeria.
NIGERIA
Two interventions will be evaluated: (i) provider intervention including introducing RDTs
with detailed instructions, one-off training, job aides and on-the-site supportive
supervisory visits and (ii) combined provider intervention [as under (i)]and community-based
intervention (using primary and secondary schools as focal points)including school malaria
events with drama, peer-health education, distribution of health education materials. Types
of facilities include: public primary health facilities, private pharmacies and private
Patent Medicine Dealers (PMDs)in Enugu State. The two sites in Enugu State are: Enugu urban
(comprising of Enugu East, Enugu South and Enugu North Local government areas (LGA) and Udi
LGA. The impact of the interventions will be evaluated using a 3-arm stratified, cluster
randomized trial with a cluster defined as a geographical community and the two study sites
as the strata. The three arms of the trial are:
- Intervention - Provider intervention
- Intervention - Provider plus school-based malaria activities
- Control - Expected practice (once RDTs have been introduced)
CAMEROON
Two interventions will be evaluated: (i) the introduction of rapid diagnostic tests (RDTs)
with basic provider training on malaria diagnosis and treatment; and (ii) the basic provider
training [as under (i)] plus enhanced provider training to improve the quality of care that
includes aspects of interactive self awareness, communication modules between health workers
and also between health workers and patients. Types of facilities include: public district
hospitals, public health centres (including integrated health centres), mission hospitals
and mission health centres (including integrated health centres)in Yaoundé and Bamenda
Health Districts. A stratified, cluster randomized trial will be used in which health
facilities are the cluster and the two study sites are the strata. The three arms of the
trial are:
- Intervention - RDTs with basic provider training;
- Intervention - RDTs with basic plus enhanced provider training;
- Control - which represents current practice and neither intervention will be
implemented.
;
Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Health Services Research
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04601714 -
Baseline Cohort Malaria Morbidity Study
|
||
Withdrawn |
NCT04020653 -
A Study to Assess the Safety and Efficacy of 5-aminolevulinic Acid Hydrochloride (5-ALA HCl) and Sodium Ferrous Citrate (SFC) Added on Artemisinin-based Combination Therapy (ACT) in Adult Patients With Uncomplicated Malaria
|
Phase 2 | |
Terminated |
NCT04368910 -
Safety and Efficacy of Pyronaridine Artesunate Vs Chloroquine in Children and Adult Patients With Acute Vivax Malaria
|
Phase 3 | |
Completed |
NCT03641339 -
Defining Skin Immunity of a Bite of Key Insect Vectors in Humans
|
N/A | |
Completed |
NCT02544048 -
Markers of T Cell Suppression: Antimalarial Treatment and Vaccine Responses in Healthy Malian Adults
|
||
Completed |
NCT00527163 -
Role of Nitric Oxide in Malaria
|
||
Not yet recruiting |
NCT05934318 -
L-ArGinine to pRevent advErse prEgnancy Outcomes (AGREE)
|
N/A | |
Active, not recruiting |
NCT04704674 -
Community Dynamics of Malaria Transmission in Humans and Mosquitoes in Fleh-la and Marshansue, Salala District, Bong County, Liberia
|
||
Completed |
NCT03276962 -
Efficacy, Safety and Immunogenicity Study of GSK Biologicals' Candidate Malaria Vaccine (SB257049) Evaluating Schedules With or Without Fractional Doses, Early Dose 4 and Yearly Doses, in Children 5-17 Months of Age
|
Phase 2 | |
Completed |
NCT04966871 -
Safety, Tolerability and Efficacy of PfSPZ Vaccine Against Heterologous CHMI in US Malaria naïve Adults
|
Phase 1 | |
Completed |
NCT00289185 -
Study of Safety, Immunogenicity and Efficacy of a Candidate Malaria Vaccine in Tanzanian Infants
|
Phase 2 | |
Recruiting |
NCT03937817 -
Collection of Human Biospecimens for Basic and Clinical Research Into Globin Variants
|
||
Active, not recruiting |
NCT06153862 -
Africa Ready Malaria Screening
|
N/A | |
Completed |
NCT04545905 -
Antenatal Care as a Platform for Malaria Surveillance: Utilizing Community Prevalence Measures From the New Nets Project to Validate ANC Surveillance of Malaria in Burkina Faso
|
||
Recruiting |
NCT06278181 -
Diabetes, Metabolic Syndrome and Risk of Malaria in Cameroon
|
||
Withdrawn |
NCT02793414 -
Diagnostic Utility of Volatile Organic Compounds in Human Breath for Acute Clinical Malaria in Ethiopia
|
||
Completed |
NCT02909712 -
Cardiac Safety of Dihydroartemisinin-Piperaquine Amongst Pregnant Women in Tanzania
|
Phase 2 | |
Withdrawn |
NCT02793388 -
A Trial on Supervised Primaquine Use in Ethiopia
|
Phase 4 | |
Completed |
NCT02793622 -
Prevention of Malaria in HIV-uninfected Pregnant Women and Infants
|
Phase 3 | |
Completed |
NCT02605720 -
Cardiac Safety of Repeated Doses of Dihydroartemisinin-Piperaquine for the Use in Mass Treatment Campaigns
|
Phase 3 |